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Abstract
This study investigates the suitability of surface-enhanced laser desorption and ionization time-of-flight (SELDI-TOF) 
and electrospray ionization (ESI) mass spectrometry for analysis of the proteins released by the mouse preimplantation 
embryo in vitro. SELDI-TOF analysis with CM10 or IMAC30 (but not Q10) protein chips detected a protein peak at m/z 
~8570 released by both C57BL6 and hybrid embryos. No other peaks unique to the presence of the embryo were 
identified with this method. ESI mass spectrometry of tryptic digests of embryo-conditioned media identified a total of 
20 proteins released during development from the zygote to blastocyst stage. Four proteins were expressed in at least 
7 out of 8 cultures tested, one of these (lactate dehydrogenase B) was in all cultures. A further five proteins were in at 
least half of the cultures and 11 more proteins were in at least one culture. The expression of two of these proteins is 
essential for preimplantation embryo development (NLR family, pyrin domain containing 5 and peptidyl arginine 
deiminase, type VI). A further four proteins detected have roles in redox regulation of cells, and three others are capable 
of inducing post-translational modifications of proteins. This study shows the feasibility of ESI mass spectrometry for 
identifying the proteins secreted by the preimplantation embryo in vitro. This analysis identifies a range of targets that 
now require detailed functional analysis to assess whether their release by the embryo is an important property of early 
embryo development.
Background
A  n u m b e r  o f  l i n e s  o f  e v i d e n c e  i n d i c a t e  t h a t  t h e  e a r l y
embryo secretes an interesting array of chemically
defined, biologically active mediators. The first such evi-
dence was the observation that early pregnancy in a num-
ber of species is associated with a detectable peripheral
thrombocytopenia [1]. This was caused by the de novo
synthesis and release by the preimplantation embryo of a
potent ether phospholipid, Paf (1-o-alkyl-2-acetyl-sn-
glycero-3-phosphocholine) [2,3]. The quantity of lipid
released by the human embryo in vitro showed a signifi-
cant association with the viability of embryos following
embryo transfer, indicating that the released factor played
an important role in embryo development [4,5].
A role for a peptide/protein secretome was inferred
from studies showing that the early embryo expressed a
range of putative trophic ligands and also their receptors
[6,7]. Evidence that the addition of one or more of these
ligands to culture media caused an improvement in the
rate of embryo development in vitro was indicative of a
functional role for their secretion by the embryo [8,9].
Some studies have detected the expression of trophic
protein ligands in spent embryo culture media (for exam-
ple, IGF-II [10]). Another example of the release of pro-
tein is the immunological mediator, HLA-G. Soluble
HLA-G is detected in spent human embryo culture
media, and the level of its expression is reported to be
positively associated with the pregnancy potential of
these embryos [11,12]. The HLA-G major histocompati-
bility antigen is thought to be a homologue of the mouse
Qa-2 antigen. This antigen is coded for by the Ped gene,
and its expression influences the rate and success of
mouse embryo development in vitro [13,14].
The development in recent years of mass spectrometry-
based proteomic techniques offer the possibility for high
throughput, cost-effective and sensitive methods for such
analysis. One of the most accessible approaches for non-
specialist in the field is the surface-enhanced laser des-
orption and ionization time-of-flight (SELDI-TOF) mass
spectrometry. The cost-effectiveness and ease of use of
this technology has meant that it has had rapid uptake.
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One study [15] used this technology to examine culture
media conditioned by mouse and human IVF embryos. A
distinct secretome was reported for mouse embryo's over
sequential 24 h intervals from fertilization until the blas-
tocyst stage. At each stage of development a number of
candidate proteins were reported to be released by the
embryo, however, the details of only one putative protein
was reported in detail. It had a molecular mass of 8.5 kDa
and after tryptic digestion was identified as ubiquitin.
The authors report that human IVF embryos also
released a range of proteins across several stages of devel-
opment, with data for a 8.5 kDa peak presented [15]. This
peak corresponded to a similar size peak detected in
media conditioned by human embryos. It was observed
that the amount of the 8.5 kDa protein released by the
embryo increased with progressive development (up to
day 5 post fertilization). Importantly, it was observed that
embryos of seemingly normal morphology released more
of this protein than those with signs of degeneration. It
was proposed that screens of these peaks might serve as
the basis for a reliable non-invasive monitoring tool for
the developmental potential of embryos generated in
vitro [15].
A limitation of the SELDI-TOF technology is that of
itself it does not provide for convenient identification of
protein peaks. An alternative proteomic strategy is the
use of conventional HPLC coupled with nano-electro-
spray ionization (ESI) mass spectrometry analysis of tryp-
tic digests of the sample of interest. Recent developments
with this methodology allow for flow rates in the low nL/
min range, which has the effect of allowing increased
analysis time span and hence increases the resolution and
sensitivity of the technique [16]. This strategy allows pro-
tein detection in the femtomolar range and thus seems
suited to analysis of the small amounts of protein released
by the preimplantation embryo.
This study compared SELDI-TOF and ESI mass spec-
trometry approaches to the analysis of the mouse preim-
plantation embryo's secretome, and shows that the two
methods generate different outcomes. ESI has the advan-




The use of animals was in accordance with the Australian
Code of Practice for the Care and Use of Animals for Sci-
entific Purpose and was approved by the Institutional
Animal Care and Ethics Committee. The strains of mice
used in experiments were: C57BL/6 (B6) and F1 (C57BL/
6 × CBA/He and CBA/He × C57BL/6; B6CBF1). All ani-
mals were housed and bred in the Gore Hill Research
Laboratory, St. Leonards, NSW, Australia, under 12 h
light: 12 h dark cycle and had access to food and water ad
libitum. Four to eight week old females were superovu-
lated by intraperitoneal injection of 5 IU equine chorionic
gonadotrophin (Folligon, Intervet International, Box-
meer, The Netherlands) followed 48 h later by 5 IU
human chorionic acid (hCG, Chorulon, Intervet).
Females were paired with males of proven fertility. Preg-
nancy was confirmed by the presence of a copulation plug
the following morning (day 0.5).
Mouse embryo collection and culture
Embryos were flushed from the reproductive tract with
Hepes-buffered modified human tubal fluid medium
(Hepes-HTF) and then cultured in modified HTF (mod-
HTF) [9]. All components of the media were tissue cul-
ture grade (Sigma Chemical Company, St Louis, MO) and
contained 30 μg bovine serum albumin (BSA)/mL unless
otherwise stated (CSL Ltd., Melbourne, Vic., Australia).
Zygotes were collected 20-21 h after hCG and freed from
their cumulus cells by brief exposure to 300 IU hyaluroni-
dase (Sigma) in Hepes-HTF. All embryos were thor-
oughly washed in three changes of Hepes-HTF. Embryos
were then recovered in a minimal volume and cultured in
10 μL volumes of mod-HTF in 60-well HLA plates (LUX
5260, Nunc, Naperville, IL) overlaid by approximately 2
mm of heavy paraffin oil (Sigma). Zygotes were cultured
in groups of 10. An equivalent number of media drops
were prepared in the same manner but did not have
embryos added to them. Culture was at 37°C in 5% CO2
for 96 h, except in one experiment where media was col-
lected after 24, 48, 72 and 96 h.
Collection of culture media
At the completion of culture, all embryos and any cellular
debris was removed from each drop in a minimum vol-
ume using a glass micropipette. The remaining media
was then withdrawn from each well and placed into a
clean sterile tube. Media was snap frozen and stored at -
70°C until its use in assays.
SELDI-TOF mass spectroscopy
Three types of 8-well format ProteinChips were used:
Cation, (CM10; cat# 573-0075), Anion (Q10; cat# 573-
0080), and IMAC (cat# 573-0078; all from Ciphergen Bio-
sciences, Inc., Fremont, CA). All washes and incubations
were performed in a humidified chamber on a rotating
shaker. Chips were pre-equilibrated with their appropri-
ate binding buffer twice for 5 minutes immediately prior
to use. The buffer used was 50 mM sodium acetate, pH 4
(Cation); 50 mM Tris, pH 9 (Anion); and 100 mM PBS,
0.01% (v/v) Triton, pH 7.4 IMAC). Prior to incubation
with binding buffer, IMAC chips were coated with copper
by incubated spots with 0.1 M copper sulphate for 10
min, followed by 2 washes in MQ water (5 min each). All
assays were performed at least 5 times.Beardsley et al. Reproductive Biology and Endocrinology 2010, 8:71
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Preliminary trials showed that dilution of sample with
buffer at a ratio of 1:4 gave the best signal to noise during
analysis and that 50 μl was the optimal volume. This
necessitated the use of a bioprocessor reservoir and gas-
ket (cat# 503-0008) which was securely placed on top of
the ProteinChip. Diluted spent or control media drops
(50 μL) were added to the each spot on the chip array.
They were incubated for 2 h at room temperature and
then washed thoroughly with excess buffer (thrice for 5
min each). Following a final rinse in 1 mM Hepes (pH 7.2)
for 2 min, the bioprocessor's reservoir and gaskets were
removed and chips allowed to air dry for no longer then
10 min. Each location on the chip was spotted with 1 μL
of the energy absorbing matrix, sinapinic acid (50% satu-
rated in 50% acetonitrile with 0.5% trifluoroacetic acid).
Chips were air dried for 3-5 min and the process
repeated. After the spots were air dried for a final time,
SELDI-TOF mass spectrometry was performed without
delay.
The arrays were read in a ProteinChip reader (Pro-
teinChip Biology System II, Ciphergen Biosystems Inc.)
in the mass/charge (m/z) range of 0-70,000. The laser
intensity was set at 220 (arbitrary units), the detector sen-
sitivity at 7 and the laser was optimised to collect data
from 3000-30,000 m/z. Data was averaged from 65 spec-
tra evenly distributed across each spot. The ProteinChip
reader was externally calibrated using known standards
(Sigma): bovine insulin (5,743.51 + 1H), equine cyto-
chrome c (12,361.96 + 1H), equine apomyoglobin
(16,952.27 + 1H) and rabbit muscle aldolase (39,212.28 +
1H); albumin present in the spent and control media
acted as an internal control.
All spectra were analysed using Ciphergen ProteinChip
Software Version 3.1 (Ciphergen Biosystems). Following
reading, spectra were baseline-subtracted and norma-
lised using the total ion current between 2,500 and 70,
000 m/z. Peaks were automatically detected if the signal/
noise ration was > 5.
Liquid chromatography - ESI mass spectrometry
Spent or control media samples (10 μL) were mixed with
25 μL NH4HCO3 (25 mM) buffer containing trypsin (50
ng). Digestion was allowed to proceed at 37°C for 14 h.
Aliquots (10 μL) of the digest were mixed with 10 μL 0.1%
(v/v) heptafluorobutyric acid (HFBA) and separated by
HPLC using an Ultimate 3000 HPLC and autosampler
system (Dionex, Amsterdam, Netherlands). Samples (5
μL) were concentrated and desalted on a micro-C18 pre-
column (500 μm × 2 mm, Michrom Bioresources,
Auburn, CA) with H2O:CH3CN (98:2, 0.05% HFBA) at 20
μL/min. After a 4 min wash the pre-column was switched
( V a l c o  1 0  p o r t  v a l v e ,  D i o n e x )  i n t o  l i n e  w i t h  a  f r i t l e s s
nano-column, as previously described [16]. Peptides were
eluted using a linear gradient of H2O:CH3CN (98:2, 0.1%
formic acid) to H2O:CH3CN (64:36, 0.1% formic acid) at
~300 nL/min over 30 min. High voltage (1800 V) was
applied to a low volume tee (Upchurch Scientific) and the
column tip positioned ~ 0.5 cm from the heated capillary
(200°C) of a LTQ FT Ultra mass spectrometer (Thermo
Electron, Bremen, Germany). Positive ions were gener-
ated by electrospray and the LTQ FT Ultra operated in
data dependent acquisition mode (DDA). The number of
replicates are show in Table 1.
A survey scan m/z 350-1750 was acquired in the FT
ICR cell (Resolution = 100,000 at m/z 400, with an initial
accumulation target value of 1,000,000 ions in the linear
ion trap). Up to the 7 most abundant ions (> 2500 counts)
with charge states of +2 or +3 were sequentially isolated
and fragmented within the linear ion trap using collision-
induced dissociation with activation q = 0.25 and activa-
tion time of 30 ms at a target value of 30,000 ions. M/z
ratios selected for MS/MS were dynamically excluded for
60 seconds.
Peak lists were generated using Mascot Daemon/
extract-msn (Matrix Science, London, England, Thermo)
using the default parameters, and submitted to the data-
base search program Mascot (version 2.1 or 2.2, Matrix
Science). Search parameters were as follows: precursor
tolerance 4 ppm and product ion tolerances ± 0.6 Da;
acrylamide, oxidation or carbamidomethyl specified as
variable modification, enzyme specificity was trypsin, 1
missed cleavage was possible and the NCBInr database
(September 2007) was searched. High scores indicated a
likely match, and in this study a score of 40 was taken as a
significant outcome.
Results and Discussion
SELDI-TOF analysis, using CM10 (cation) chips showed
a large peak with a m/z of ~66,000, which is assumed to
be the BSA added to media. There were also smaller
peaks at 33,000, 22,000, 13,700 and 8,800 m/z (Fig 1). The
33,000 and 22,000 m/z peaks were likely to be double and
triple ionized albumin; the other two peaks are unidenti-
fied. In media conditioned by preimplantation embryos,
only one unique additional protein peak was observed,
this was consistently detected at ~8570 m/z. This peak
was detected in media of conditioned by either B6 or F1
embryos. The peak could be detected after culture of
zygotes for 24 h, and increased its signal strength with the
duration of culture of embryos (Fig. 2).
A similar pattern of expression of proteins was detected
when IMAC30 (loaded with Cu2+) protein chips were
used (Fig 3). The embryo-derived 8570 m/z peak detected
with CM10 chips was also detected using the IMAC30.
This chip also detected additional 7550 m/z and 8775 m/z
peaks, but these were detected in both both conditioned
and control media.Beardsley et al. Reproductive Biology and Endocrinology 2010, 8:71
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The same experiment was conducted using the Q10
(anion) chips. Using a number of different variables
including modification of the binding buffer for molarity
and pH, sample concentration, incubation times,
increased sensitivity and laser intensity of the Pro-
teinChip reader, the unique protein peak detected in both
CM10 and IMAC chips was not detected. The 3 BSA
peaks (at 66,000, 33,000 and 22,000 m/z) were detected
on these chips, however, no unique embryo-dependent
peaks were observed (data not shown).
To determine the reliability of analysis, replicate media
samples was prepared as individual aliquots. The samples
were analyzed on each of the chip surfaces (CM10 and
IMAC) on several repeat occasions and the average peak
intensities and m/z ratios assessed for inter-chip variabil-
ity. Using the BSA peaks, the inter-assay coefficient of
variability on the IMAC chip was 34% for peak intensity
and 0.21% for mass accuracy. The inter-assay coefficient
of variability on the CM10 was 40% for peak intensity and
0.13% for mass accuracy.
Using the same settings and conditions for all analyses,
SELDI-TOF mass spectrometry consistently detected a
putative protein peak of ~8570 m/z. The intensity of this
band was well above all putative noise signals and it was
likely to be a genuine protein released by the mouse pre-
implantation embryo. Its size and behavior seems to be
similar to a peak of 8500 Da previously reported [15] to
be ubiquitin released from mouse and human embryos in
vitro.
In an attempt to confirm the molecular characteristics
of this peak we undertook ESI mass spectrometry of tryp-
tic digests of control and conditioned media. Control
media consistently reported strong signals for bovine
serum albumin, but also commonly provided detectable,
Table 1: Protein signals detected by ESI mass spectrometry in eight B6 or F1 embryo-conditioned media
Protein name Mr (Da) Average score Gi # Positive cultures Strain distribution 
B6:F1 (M) *
Lactate dehydrogenase B 36,549 358 ± 48 6678674 8 3:4 (1)
Peptidyl arginine deiminase, Type VI 76,855 375 ± 84 23346537 7 3:3 (1)
Tyrosine 3-monooxygenase/tryptophan 
5-monooxygenase activation protein, zeta/
delta polypeptide
27,839 117 ± 24 112696 7 3:4 (0)
Calreticulin 47,965 115 ± 20 6680836 7 3:3 (1)
Prolyl 4-hydroxylase, beta polypeptide 
(ERp59)
57,108 116 ± 16 129729 5 2:3 (0)
NLR family, pyrin domain containing 5 125,421 169 ± 48 7106379 4 2:2 (0)
Oviductal glycoprotein 1 78,758 180 ± 53 33468849 4 2:2 (0)
Protein disulfide-isomerase A3 (ERp61) 2,121 73 ± 7 545439 4 2:2 (0)
Tyrosine 3-monooxygenase/tryptophan 
5-monooxygenase activation protein, gamma 
polypeptide
28,345 94 ± 26 3065929 4 2:2 (0)
Glycogenin 1 37,378 84 7305121 2 1:1 (0)
Zinc finger, BED domain containing 3 25,293 114 21312432 2 1:1 (0)
Transducin-like enhancer of split 6 65,074 77 16716583 2 1:1 (0)
2,3-bisphosphoglycerate mutase 29,960 91 6680806 2 1:1 (0)
Peroxiredoxin 1 22,162 150 6754976 1 1:0 (0)
Phosphatidylethanolamine binding protein 20,847 127 1517864 1 1:0 (0)
F-box domain containing protein 54,417 127 28892973 1 1:0 (0)
Heat shock protein HSP 90-alpha 84,735 114 6754254 1 1:0 (0)
Spindlin isoform 1 27,119 60 6755620 1 0:1 (0)
Peptidylprolyl isomerase A 17,960 54 6679439 1 0:1 (0)
2'-5' oligoadenylate synthetase 1C 42,884 53 15809044 1 1:0 (0)
# GI number of the 
protein database 
record at NCBI
* Distribution of 
positive cultures - M is 
mixed of B6 and F1Beardsley et al. Reproductive Biology and Endocrinology 2010, 8:71
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but weaker, signals for transthyretin (Bos Taurus, pre-
dicted size 15,717 Da, also known as prealbumin), alpha-
1 acid glycoprotein (Bos Taurus, predicted size 23,168
Da) and complement component C3 (Bos Taurus, pre-
dicted size 23,187 kDa). Embryo-conditioned media
expressed these proteins, but also displayed a range of
other unique signals (Table 1). This analysis did not
detect targets that had a predicted mass of 8570, nor did
it detect ubiquitin or related proteins. Four of the protein
signals were expressed in at least 7 out of 8 cultures
tested, one of these (lactate dehydrogenase B) generated a
strong signal in all cultures tested. A further 5 protein sig-
nals were detected in at least half of the cultures (4/8). A
further 11 proteins were detected in at least one culture
tested. We found no obvious difference between B6 or
hybrid embryos in the pattern of the secretome detected.
The score shown for each peak gives a semi-quantitative
measure of the relative abundance of the protein. For
comparison, 30 μg BSA/mL gave a score of 932 ± 40. In
one replicate of the experiment using ESI mass spectros-
copy several isoforms of human keratin was detected,
suggesting likely operator contamination of the sample.
The results confirm the capacity of SELDI-TOF to
detect a ~8570 protein released by the mouse preimplan-
tation embryo in vitro. We were not able to confirm its
identity as ubiquitin using mass spectrometry of tryptic
digests of embryo conditioned media. The study showed
ESI mass spectrometry was a more sensitive tool for the
detection of the secretome and this method detected a
diverse, yet variable, secretome that is generated by the
mouse preimplantation embryo in vitro. This method
identified a total of 20 putative proteins released by
embryos into their culture media during their develop-
ment from the zygote to blastocyst stage. Several of these
Figure 1 SELDI-TOF analysis of conditioned culture media from (A) F1 blastocysts and (B) media alone on the CM10 protein chip. Chip profile 
shows m/z 3000-70,000 in both trace and gel views. Protein peaks were detected in the media at m/z values coinciding with the molecular weight of 
BSA proteins (66, 33, 22 and 13.7kDa). A protein peak of ~8570 (*) was detected in the conditioned culture media (a'), but not in the media only sam-
ples (b') which contained no developing embryos.Beardsley et al. Reproductive Biology and Endocrinology 2010, 8:71
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proteins are known to be expressed by the embryo at high
levels, and one of them (calreticulin) has been previously
reported to be released by the embryo (hamster [17]). By
contrast, the study found that in our hands SELDI-TOF
only consistently detected one signal. The settings used
gave consistent results, while increased sensitivity gener-
ated unsatisfactory signal to noise response, creating the
dangers of artifactual readings. SELDI-TOF consistently
detected a peak of ~8570 Da. The interassay coefficient of
variation of ~40% indicates that care needs to be applied
to any quantitative interpretation of such analyses.
The 8570 Da peak detected in this study shares many of
the characteristics as the 8500 Da band that was detected
in a previous study [15], which was identified as ubiq-
uitin. However, in our hands, ESI analysis of tryptic
digests of spent media did not detect ubiquitin or any
protein with a predicted mass of 8500 or 8570 Da. It is
possible that the 8570 Da peak detected by SELDI-TOF
was not a whole protein but a consistently generated frag-
ment of one of the other proteins identified by ESI (all but
one of the peaks detected by mass spectrometry had a full
length size greater than 8570 Da). It should also be noted
that since the ESI was performed on tryptic digests, it can
not be inferred that the intact protein of all peaks identi-
fied were present within conditioned media.
It was suggested that the release of the protein detected
by SELDI-TOF may be a marker for embryo viability and
developmental potential [15]. We used the well known
difference in the developmental potential of inbred
mouse strains (C57BL6) compared with hybrid strains
(B6CBF1) [18] to assess whether this difference in devel-
opmental potential was reflected in differences in the
8570 Da protein. We found no consistent difference
between the two strains in the expression of this protein.
The ESI analysis showed that for the most abundant sig-
nals no clear difference between strains was evident,
however, seven of the signals detected only occurred in
one strain or the other (Table 1).
Of the proteins detected, the expression of two has
been shown to be essential for the normal development
of the embryo (Table 2). MATER (maternal antigen that
embryos require; NLRP5) is an oocyte-specific protein
that persists in the early embryo. Nlrp5 null oocytes show
normal fertilization and first cleavage, but embryos die
soon thereafter, with most becoming blocked at the 2-cell
stage. MATER is associated with another protein (FILIA)
to form complexes that localized to the periphery of the
cells composing the embryo [19,20]. This only occurred
in apical membranes not in contact with neighboring
cells, and may be a source of positional information for
the embryo. Peptidyl arginine deiminases (PAD) are a
family of post-translational protein modifying enzymes
that deiminate arginine into citrulline in the presence of
calcium. PADs are involved with cytoskeletal and chro-
matin reorganization. PAD type VI (ePAD), found here to
be released by the embryo, is abundantly expressed in the
ovary and weakly in the testis. It is expressed throughout
the pre-implantation stage, however, expression
decreases at the blastocyst stage [21]. The immunolocal-
ization in the early embryo was detected throughout the
cytoplasm [21] and was present on the plasma membrane
around oocytes (unfertilized) and during the preimplan-
tation stage. Anti-ePAD antibodies incubated with devel-
oping embryos (from zygote to blastocyst) perturbed
development of these embryos [22]. More strikingly, fer-
tilization of oocytes that were Padi6-null were normal,
but the resulting zygotes failed to develop past the 8-16-
cell stage of development [23]. Conversely, fertilization of
sperm from Padi6-null males resulted in normal develop-
ment. The results are interpreted as evidence that ePAD
is a maternal effect protein essential for normal develop-
ment.
Of the other proteins released, four are known to func-
tion in the regulation of cellular redox status. The redox
status of the early embryo has been the focus for much
research and has guided the current design of media.
Lactate dehydrogenase B is known to be higher in mouse
zygotes than in blastocysts [24]. Pyruvate is the preferred
nutrient (over glucose) in the early mouse embryo, how-
ever, after the 8-cell/morula stage, glucose is taken up
preferentially in both mouse [25] and human [26]
embryos. The detection of two protein disulfide
isomerases suggests that extracellular protein remodeling
is an important function during early embryo develop-
ment. The expression of a range of other enzymes that
have roles in post-translational modification add weight
to this likely function. Protein disulfide isomerases are
known to be highly abundant in a range of cells, and in
Figure 2 SELDI-TOF analysis of conditioned culture media taken 
24, 48, 72 and 96 h after culture of F1 zygotes using the CM10 
chip. The relative changes in the amplitude of the 8570 m/z peak for 
media from F1 embryos. Results are the mean + SEM.Beardsley et al. Reproductive Biology and Endocrinology 2010, 8:71
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some cells it undergoes constant shedding and replace-
ment from intracellular stores [27]. To our knowledge,
protein disulfide isomerases activity in the early embryo
has not been directly investigated, although a require-
ment for the action of protein disulfide isomerases was
postulated to account for the disulfide bond rearrange-
ment in extracellular albumin that accompanied the
release of the important embryotrophin Paf from the pre-
implantation embryo [28,29]. Since both ERp59 and
ERp61 are normally in the endoplasmic reticulum, their
detection in conditioned medium may suggest suggest
that the early embryo's membrane may be actively
remodeled by vesicular fusion.
Calreticulin (CRT) is a low affinity, high capacity bind-
ing molecule for calcium ions, regulating the concentra-
tion of calcium in the endoplasmic reticulum. It also has
many other roles including chaperonin activity, regula-
tion of cell adhesion, and modulation of steroid-mediated
gene expression [30]. CRT is an upstream regulator of
calcineurin (a calcium-sensitive phosphatases) and a neg-
ative regulator of MDM2 activity, and hence fosters acti-
vation of the TRP53 pathway [30]. Evidence from a
number of cell types indicates that CRT is an important
secreted protein [31]. CRT has been immunolocalized in
the human oocyte and early embryo [32] where it is con-
centrated at the cell cortex (outside of the cell). In the
mouse, CRT has been immunolocalized in oocytes and 1-
cell embryos. In fixed cells, CRT was detected as punctu-
ate staining throughout the cytoplasm, which is consis-
tent with the staining of the endoplasmic reticulum. CRT
was also detected in living oocytes and 1-cell embryos;
staining was most predominant on the extracellular sur-
face of the embryo. Staining appeared to be brighter in
the 1-cell embryo compared with oocytes [33]. The ER
derived chaperonins, protein disulfide isomerase and
CRT have activities in processing cell surface proteins
such as the MHC class I antigen [34]. Given the impor-
tant role of the Qa2 (MHC class I) antigen in determining
the embryo's rate of growth [35], it will be an attractive
Figure 3 SELDI-TOF analysis of conditioned culture media from F1 (A), C57 (B) animals and media alone (C) on the IMAC30 protein chip. 
Chip profile shows m/z 3000-70,000. Similar to the CM10 chip, peaks were detected in the media at molecular weights coinciding with BSA proteins. 
A) Gel and trace view of F1 conditioned media. B) Gel view of C57 conditioned media. C) Gel view of media that did not contain developing embryos. 
A protein peak of ~8570 (*) was detected in the conditioned culture media from both F1 (a') and C57 (b') media, but not in the media only samples (c')Beardsley et al. Reproductive Biology and Endocrinology 2010, 8:71
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Table 2: Common and Gene names, and main known functions of the protein signals detected by ESI mass spectrometry
Protein name Common Name Gene Name Main Function, where known
Essential for preimplantation 
development
NLR family, pyrin domain containing 5 Mater Nlrp5 Cell surface expression protein essential for normal early embryo 
development
Peptidyl arginine deiminase, type VI ePAD Padi6 Catalyzes the deimination of arginine residues of proteins. May 
be involved in cytoskeletal reorganization in the egg and early 
embryo.
Modification of proteins
Peptidylprolyl isomerase A cyclophilin A Ppia Catalyzes the cis-trans isomerization of proline imidic peptide 
bonds in oligopeptides, accelerates the folding of proteins.
Tyrosine 3-monooxygenase/tryptophan 
5-monooxygenase activation protein, 
zeta/delta polypeptide
14-3-3 zeta Ywhaz Adapter protein that binds to a large number of partners by 
recognition of a phosphoserine or phosphothreonine motif. 
Generally results in the modulation of the activity of the binding 
partner.
Tyrosine 3-monooxygenase/tryptophan 
5-monooxygenase activation protein, 
gamma polypeptide
14-3-3 gamma Ywhag As above.
REDOX regulation
Lactate dehydrogenase B LHD-2 Ldhb Catalyzes reaction: (S)-lactate + NAD(+) = pyruvate + NADH.




P4hb Catalyzes the formation, breakage and rearrangement of 
disulfide bonds. Present at high levels in many cells and actively 
shed by many cells.
Protein disulfide-isomerase A3 (ERp61) Protein disulfide-
isomerase
Pdia3 Catalyzes the formation, breakage and rearrangement of 
disulfide bonds
Peroxiredoxin 1 Thioredoxin 
peroxidase 2
Prdx1 Catalyzes reactions: 2 R'-SH + ROOH = R'-S-S-R' + H(2)O + ROH.
Chaperonins
Calreticulin Calregulin Calr Calcium binding chaperonin, promotes protein folding. Can act 
as a cell surface lectin.
Heat shock protein HSP 90-alpha HSP 90 Hsp90aa1 A stress actvated chaperonin with ATPase activity. Many cellular 
functions and targets.
2'-5' oligoadenylate synthetase 1C Oas1c Interferon activated anti-viral agent
Miscellaneous or Ill-defined function
Spindlin isoform 1 30000 metaphase 
complex
Spin1 A meiotic spindle binding protein present in oocytes.
Glycogenin 1 Gyg1 Self-glucosylates forming oligosaccharide primer for glycogen 
synthase
Transducin-like enhancer of split 6 Groucho-related 
protein 6
Tle6 Transcriptional co-repressor that binds to a number of 
transcription factors. Inhibits the transcriptional activation 




Bpgm Regulates hemoglobin oxygen affinity. Catalyzes reaction: 3-
phospho-D-glyceroyl phosphate = 2,3-bisphospho-D-glycerate.
Phosphatidylethanolamine binding 
protein
HCNPpp Pebp1 Binds ATP, opioids and phosphatidylethanolamine. Serine 
protease inhibitor, may be involved in the function of the pre-
synaptic cholinergic neurons of the central nervous system.
Zinc finger, BED domain containing 3 Zbed3 Still to be defined, transcripts detected in 2-cell embryo library
F-box domain containing protein F-box domain is approximately 50 amino acids long and is found 
in the N-terminal half of a variety of proteins commonly 
associated with the leucine rich repeats
Oviductal glycoprotein 1 OGP Ovgp1 Belongs to the glycosyl hydrolase 18 family. Released by oviduct, 
binds to zona pelleucida.Beardsley et al. Reproductive Biology and Endocrinology 2010, 8:71
http://www.rbej.com/content/8/1/71
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hypothesis to test whether these chaperonins have a role
in processing this antigen in the embryo.
Oviduct-specific glycoprotein is secreted by the oviduct
under the effect of oestrogen [36]. It interacts with the
gametes and early embryo in several mammalian species,
and has been implicated as a paracrine regulator of fertil-
ization and early embryo development, yet deletion of the
gene for this protein has no effect of fertility [37]. Its
detection indicates that this paracrine factor may be
released from the embryo after its initial binding to the
oocyte/embryo.
It is noteworthy that this highly sensitive method of
identifying proteins in media did not detect some of the
expected targets such as the HLA-G homologue Qa-2,
IGF-II, ubiquitin, or the range of other protein growth
factors thought to have potential autocrine roles. This
may mean that these factors are released at levels too low
to be detected by these methods. Alternatively, it may
mean that these factors still act as trophic factors for the
embryo, but do not do so in the soluble phase.
This study shows the feasibility of using high resolution
and sensitive ESI mass spectrometry for identifying the
secretome generated by the preimplantation embryo, and
other sources where the amount of biological material is
limited. There was considerable variability between cul-
tures in the range of proteins detected, and further stud-
ies are required to determine whether this variability is
informative of the embryo's status or developmental fate,
or simply reflects the limits of the sensitivity of the tech-
nology. The study further shows that while the SELDI-
TOF technology is an inferior approach to assessment of
the embryo's secretome compared to ESI mass spectrom-
etry. This study identifies a range of targets that now
required detailed functional analysis to assess where their
release by the embryo are an important property of early
embryo development.
Conclusions
This study shows that ESI mass spectrometry of tryptic
digests of embryo-conditioned culture media provides a
sensitive method for detecting and identifying the range
of protein products that are released by the embryo into
its surrounding environment. This will provide an impor-
tant tool for analyzing the between-embryo communica-
tion and embryo-maternal communication thought to
form an important part of the normal processes of early
pregnancy.
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